Literature DB >> 2028451

Comparative study of the fibrinolytic system in human fetuses and in pregnant women.

P Reverdiau-Moalic1, Y Gruel, B Delahousse, A Rupin, M C Huart, G Body, J Leroy.   

Abstract

Levels of major parameters of fibrinolysis were measured in 50 normal human fetuses between 19 and 39 weeks of gestation and compared to those of 50 healthy normal pregnant women and 30 adult controls. In fetuses, euglobulin clot lysis time (ECLT) was significantly shortened, plasminogen level was low and histidine-rich glycoprotein undetectable. While t-PA and u-PA levels were slightly lower than in adult controls, a significant decrease in PAI activity was demonstrated and no PAI-2 could be detected in fetal plasma. In contrast with these findings, the fibrinolytic equilibrium of pregnant women exhibited a prolonged ECLT and a strong increase in both PAI activity and PAI-2 antigen levels, while only a moderate elevation in u-PA and t-PA levels was measured.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2028451     DOI: 10.1016/0049-3848(91)90157-r

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Profibrinolytic microparticles are not adequately produced to compensate their prothrombotic effect.

Authors:  Rucha Patil; Kanjaksha Ghosh; Shrimati Shetty
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

Review 3.  Developmental hemostasis in the neonatal period.

Authors:  Vicente Rey Y Formoso; Ricardo Barreto Mota; Henrique Soares
Journal:  World J Pediatr       Date:  2022-01-04       Impact factor: 2.764

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.